Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22615 | 374 | 32.0 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
456 | 3 | VIRGIN OLIVE OIL//OLIVE OIL//HYDROXYTYROSOL | 25234 |
1534 | 2 | OXIDIZED LDL//ATHEROSCLEROSIS//LOX 1 | 7455 |
22615 | 1 | PROBUCOL//AGI 1067//SUCCINOBUCOL | 374 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROBUCOL | authKW | 1483131 | 24% | 20% | 89 |
2 | AGI 1067 | authKW | 419885 | 2% | 86% | 6 |
3 | SUCCINOBUCOL | authKW | 226086 | 2% | 46% | 6 |
4 | VASCULAR PROTECTANT | authKW | 163289 | 1% | 100% | 2 |
5 | ANGIOTENSIN CONVERTING ENZYME INHIBITOR PROBUCOL | authKW | 81645 | 0% | 100% | 1 |
6 | APO A I CONTAINING LIPOPROTEIN | authKW | 81645 | 0% | 100% | 1 |
7 | ARTERIOGRAPHY ATHEROSCLEROSIS | authKW | 81645 | 0% | 100% | 1 |
8 | ARTERIOSCLEROSIS FEMORAL ARTERY | authKW | 81645 | 0% | 100% | 1 |
9 | ATHEROSCLEROSIS QUANTITATION | authKW | 81645 | 0% | 100% | 1 |
10 | BALLOON INJURED | authKW | 81645 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 3819 | 40% | 0% | 149 |
2 | Peripheral Vascular Diseases | 2862 | 26% | 0% | 97 |
3 | Pharmacology & Pharmacy | 186 | 15% | 0% | 57 |
4 | Medicine, General & Internal | 99 | 9% | 0% | 34 |
5 | Medicine, Research & Experimental | 91 | 7% | 0% | 26 |
6 | Endocrinology & Metabolism | 42 | 5% | 0% | 20 |
7 | Chemistry, Medicinal | 20 | 3% | 0% | 11 |
8 | Biochemistry & Molecular Biology | 18 | 11% | 0% | 40 |
9 | Medical Laboratory Technology | 16 | 1% | 0% | 5 |
10 | Biophysics | 12 | 3% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BASIC MED NOSOG | 81645 | 0% | 100% | 1 |
2 | FRANZ VOLHARD CLIN MAX DELBRUCK | 81645 | 0% | 100% | 1 |
3 | GEN MED NW HLTH BOARD | 81645 | 0% | 100% | 1 |
4 | HOSPNET INTERVENT STUDY DIABET NEPHROPATHY | 81645 | 0% | 100% | 1 |
5 | HPINSERM E00 16 | 81645 | 0% | 100% | 1 |
6 | INTERVENT CARDIOL CARDIAC CATHETERIZATION | 81645 | 0% | 100% | 1 |
7 | MED STAT LIFE INSURANCE CO | 81645 | 0% | 100% | 1 |
8 | NEPHROL CLIN KIDNEY DISBEIJING | 81645 | 0% | 100% | 1 |
9 | POST MKT SURVEILLANCE ADM | 81645 | 0% | 100% | 1 |
10 | PROGRAM POST HLTH SCI CARDIOL CARDIOVASC SC | 81645 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTERY | 61580 | 5% | 4% | 20 |
2 | ATHEROSCLEROSIS | 11700 | 10% | 0% | 39 |
3 | AMERICAN JOURNAL OF CARDIOLOGY | 3122 | 9% | 0% | 32 |
4 | CLINICAL TRIALS AND META-ANALYSIS | 2914 | 0% | 4% | 1 |
5 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 1821 | 1% | 0% | 5 |
6 | ACTA RADIOLOGICA | 1776 | 3% | 0% | 10 |
7 | KARDIOLOGIYA | 1236 | 3% | 0% | 10 |
8 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1079 | 2% | 0% | 8 |
9 | ARTERIOSCLEROSIS AND THROMBOSIS | 872 | 1% | 0% | 3 |
10 | NOUVELLE PRESSE MEDICALE | 742 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YAMASHITA, S , MASUDA, D , MATSUZAWA, Y , (2015) DID WE ABANDON PROBUCOL TOO SOON?.CURRENT OPINION IN LIPIDOLOGY. VOL. 26. ISSUE 4. P. 304 -316 | 45 | 44% | 4 |
2 | BUCKLEY, MMT , GOA, KL , PRICE, AH , BROGDEN, RN , (1989) PROBUCOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERCHOLESTEROLEMIA.DRUGS. VOL. 37. ISSUE 6. P. 761-800 | 50 | 61% | 124 |
3 | MULDREW, KM , FRANKS, AM , (2009) SUCCINOBUCOL: REVIEW OF THE METABOLIC, ANTIPLATELET AND CARDIOVASCULAR EFFECTS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 18. ISSUE 4. P. 531 -539 | 22 | 58% | 13 |
4 | TANOUS, D , HIME, N , STOCKER, R , (2008) ANTI-ATHEROSCLEROTIC AND ANTI-DIABETIC PROPERTIES OF PROBUCOL AND RELATED COMPOUNDS.REDOX REPORT. VOL. 13. ISSUE 2. P. 48-59 | 35 | 35% | 10 |
5 | STOCKER, R , (2009) MOLECULAR MECHANISMS UNDERLYING THE ANTIATHEROSCLEROTIC AND ANTIDIABETIC EFFECTS OF PROBUCOL, SUCCINOBUCOL, AND OTHER PROBUCOL ANALOGUES.CURRENT OPINION IN LIPIDOLOGY. VOL. 20. ISSUE 3. P. 227-235 | 27 | 41% | 24 |
6 | YAMASHITA, S , MASUDA, D , OHAMA, T , ARAI, H , BUJO, H , KAGIMURA, T , KITA, T , MATSUZAKI, M , SAITO, Y , FUKUSHIMA, M , ET AL (2016) RATIONALE AND DESIGN OF THE PROSPECTIVE TRIAL: PROBUCOL TRIAL FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC EVENTS IN PATIENTS WITH PRIOR CORONARY HEART DISEASE.JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. VOL. 23. ISSUE 6. P. 746 -756 | 23 | 43% | 0 |
7 | TITOV, VN , (1995) CHOLESTEROL TURNOVER IN TRIGLYCERIDE TRANSPORT AND PROBUCOL ACTION.VOPROSY MEDITSINSKOI KHIMII. VOL. 41. ISSUE 5. P. 2-8 | 30 | 57% | 1 |
8 | LIU, JC , LI, MH , LU, H , QIAO, WG , XI, D , LUO, TT , XIONG, HW , GUO, ZG , (2015) EFFECTS OF PROBUCOL ON RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS.PLOS ONE. VOL. 10. ISSUE 4. P. - | 21 | 43% | 2 |
9 | LANKIN, VZ , LUPANOV, VP , LYAKISHEV, AA , REVENKO, VM , (1991) MECHANISMS OF ANTIATHEROGENIC ACTION OF PROBUCOL AND PROSPECTS OF ITS CLINICAL-APPLICATION.KARDIOLOGIYA. VOL. 31. ISSUE 6. P. 87 -90 | 35 | 56% | 2 |
10 | STRANDBERG, TE , VANHANEN, H , MIETTINEN, TA , (1988) PROBUCOL IN LONG-TERM TREATMENT OF HYPERCHOLESTEROLEMIA.GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM. VOL. 19. ISSUE 3. P. 317-320 | 26 | 81% | 13 |
Classes with closest relation at Level 1 |